PRRT of Neuroendocrine Tumors: Individualized Dosimetry or Fixed Dose Scheme?

EJNMMI Research - Germany
doi 10.1186/s13550-020-00623-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Small Pancreatic Neuroendocrine Tumors: Resect or Enucleate?

HPB
HepatologyGastroenterology
2019English

Salvage PRRT With 177Lu-Dota-Octreotate in Extensively Pretreated Patients With Metastatic Neuroendocrine Tumor (NET): Dosimetry, Toxicity, Efficacy, and Survival

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Comparative Biodistribution and Radiation Dosimetry of 68Ga-Dotatoc and 68Ga-Dotatate in Patients With Neuroendocrine Tumors

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

Pancreatic Neuroendocrine Tumors

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2017English

Cytotoxic Treatment of Aggressive Prostate Tumors With or Without Neuroendocrine Elements

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2002English

Neuroendocrine Tumors of the Breast

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2017English

Embolotherapy for Neuroendocrine Tumors

Digestive Disease Interventions
SurgeryNuclear MedicineRadiologyImagingGastroenterology
2019English

Association of Intraductal Papillary Mucinous Neoplasm and Pancreatic Neuroendocrine Tumors: Myth or Reality?

HPB
HepatologyGastroenterology
2017English

Neuroendocrine Tumors of the Fallopian Tube

International Journal of Gynecological Pathology
GynecologyForensic MedicinePathologyObstetrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy